Arfysica Innovation

Chinese BCI (brain-computer interface) companies are moving toward public listings on Shanghai's STAR Market. Arfysica Innovation, founded in 2015 and focused on BCI products for central nervous system injuries and cognitive disorders, has registered for IPO coaching. Neuracle Medical Technology, maker of the NEO implant (the first approved commercial invasive BCI, beating Neuralink), has signed a coaching agreement with CITIC Securities.